DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online support, community stories, financial assistance
Lloyd Smith – Amyloidosis Patient Story
In late 2019, Lloyd Smith was suffering with symptoms that were later thought to be COVID-19, although he never had a conclusive test. At the time, the world was still struggling to understand the virus, and Lloyd avoided health care settings as the media was recommending.
Months later, he was struggling to even make the short walk to the mailbox and back. “I went from being healthy, normal and active to being a zombie,” he says. “My breathing was so shallow, and I was gasping for air. Because I lived alone, every day was a struggle.”
Knowing he needed answers, Lloyd began researching his options. “Even before I had my appointment at The James, I knew I had found five-star doctors because I did my homework, and I was also told by a friend that that would be my best option for treatment.”
Related Content
-
educationNovel Approaches for the Management of AL AmyloidosisPurpose of Review: Light-chain-associat...
-
videos & visualsFinancial Assistance Update: Paula Schmitt – ASG Webinar 5/13https://www.youtube.com/watch?v=NrEjyVeJ...
-
news & meetingsAmyloidosis Support Groups Webinar on ATTRv and ATTRwt AmyloidosisPlease join us on January 21st, 2023 fro...
-
videos & visualsTransthyretin Cardiac Amyloidosis (ATTR-CM) Signs, Symptoms, and Diagnostic Approach – ASG Webinar 1/11https://www.youtube.com/watch?v=K2TmwAfu...
-
educationTransthyretin Cardiac AmyloidosisPurpose of Review: Transthyretin (TTR)-...
-
videos & visualsSteroids – ASG Webinar 4/13https://www.youtube.com/watch?v=4gUXPbOk...
-
news & meetingsFDA Approves Subcutaneous Daratumumab Plus VCd for Newly Diagnosed Light-Chain AmyloidosisThe FDA has approved daratumumab and h...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.